Cargando…
Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
Autor principal: | Suh, Chang-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Rheumatology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327617/ https://www.ncbi.nlm.nih.gov/pubmed/37475895 http://dx.doi.org/10.4078/jrd.2022.29.2.59 |
Ejemplares similares
-
Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis
por: Almutairi, Abdulaziz, et al.
Publicado: (2018) -
Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010) -
Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008) -
Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016) -
Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis
por: Diaz-Rizo, Valeria, et al.
Publicado: (2017)